Table 3.
Characteristics of cancer survivors by cancer type.
| Colon (n = 279) | Rectal (n = 227) | p-Value b | |||
|---|---|---|---|---|---|
| n | % MI a | n | % MI a | ||
| Sex | 0.2 | ||||
| Female | 121 | 43.4 | 86 | 37.9 | |
| Male | 158 | 56.6 | 141 | 62.1 | |
| Age at survey | 0.9 | ||||
| <65 years | 27 | 9.7 | 25 | 11.0 | |
| 65–74 years | 64 | 22.9 | 54 | 23.8 | |
| 75–84 years | 149 | 53.4 | 119 | 52.4 | |
| ≥85 years | 39 | 14.0 | 29 | 12.8 | |
| Mean age at survey (SD) | 76.3 | (8.6) | 75.8 | (8.1) | 0.5 |
| Mean time since diagnosis | 16.7 | (2.6) | 16.8 | (2.5) | 0.8 |
| Cancer stage at diagnosis (UICC) | 0.1 | ||||
| I | 70 | 25.2 | 73 | 32.2 | |
| II | 112 | 40.0 | 72 | 31.8 | |
| III | 83 | 29.7 | 74 | 32.8 | |
| IV | 14 | 5.1 | 7 | 3.3 | |
| Primary treatment | |||||
| Surgery | 221 | 79.4 | 193 | 85.2 | 0.09 |
| Chemotherapy | 120 | 42.9 | 121 | 53.2 | 0.02 |
| Radiotherapy | 23 | 8.2 | 103 | 45.5 | <0.0001 |
| Immuno-/antibody therapy | 5 | 5.2 | 5 | 2.3 | 0.09 |
| Permanent stoma | 2 | 0.7 | 53 | 23.3 | <0.0001 |
| Disease progression | 0.7 | ||||
| None | 208 | 74.6 | 170 | 74.9 | |
| Between diagnosis and 1st survey | 30 | 10.8 | 20 | 8.8 | |
| Between 1st and 2nd survey | 41 | 14.7 | 37 | 16.3 | |
| Number of comorbidities | 0.7 | ||||
| None | 60 | 21.6 | 55 | 24.3 | |
| One | 60 | 21.6 | 41 | 18.1 | |
| Two to three | 96 | 34.3 | 77 | 34.0 | |
| Four or more | 63 | 22.5 | 54 | 23.6 | |
Percentages might not add up to 100% due to rounding up. a MI: based on 25 imputations. b p-values of chi-squared tests. UICC: Union for International Cancer Control classification. Statistically significant p-values are highlighted in bold (p < 0.05).